首页> 外国专利> A process for the preparation of pure, crystalline, sparingly soluble salts of phenoxymethylpenicillin.

A process for the preparation of pure, crystalline, sparingly soluble salts of phenoxymethylpenicillin.

机译:一种制备纯的,结晶的,微溶的苯氧基甲基青霉素盐的方法。

摘要

Substantially pure, crystalline, salts of phenoxymethylpenicillin with a benzimidazole compound are produced by reacting phenoxymethylpenicillanic acid, or a metal salt thereof, with a benzimidazole compound of formula FORM:1023385/C2/1 wherein R1 is an aliphatic hydrocarbon residue containing at least one secondary or tertiary amino group and R2 is an aralkyl or substituted aralkyl residue, or a salt thereof, in a suspending liquid wherein the phenoxymethyl penicillin is difficultly soluble and the benzimidazole is readily soluble at a temperature not substantially exceeding 60 DEG C., adding to the resulting mixture seed crystals of the final product in an amount between 5 and 10% of said desired salt, said seed crystals having a particle size between 5 and 20 microns, and slowly cooling the seeded reaction mixture. An initial temperature of 40 to 50 DEG C., with cooling not in excess of 50 DEG C. every 30 minutes, together with stirring, is preferable. Dispersing agents such as lecithin may be present. The above penicillin V salts of benzimidazole may be administered parenterally in aqueous suspension with or without a dispersing aid.
机译:通过使苯氧甲基青霉酸或其金属盐与式的苯并咪唑化合物反应,制得基本上纯的结晶的苯氧甲基青霉素与苯并咪唑化合物的盐,其中R1为至少包含在悬浮液中苯氧基甲基青霉素难溶且苯并咪唑在不超过60℃的温度下容易溶解的悬浮液中,一个仲或叔氨基和R 2为芳烷基或取代的芳烷基残基或其盐。得到的最终产物的晶种的量为所述所需盐的5-10%,所述晶种的粒径为5-20微米,并缓慢冷却晶种的反应混合物。初始温度为40至50℃,同时每30分钟冷却不超过50℃是优选的,同时搅拌。可能存在诸如卵磷脂的分散剂。苯并咪唑的上述青霉素V盐可以在水性悬浮液中在有或没有分散助剂的情况下肠胃外给药。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号